Matches in Nanopublications for { ?s ?p "[In conclusion, the CCR5 Delta 32 polymorphism attenuates the adverse effects of inflammation on overall and cardiovascular mortality in ESRD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 10 of
10
with 100 items per page.
- NP825673.RAu-mXbnJHo5wRUzLd3aGpKdV8s-rO7i_brvXDdQ6x8-M130_assertion description "[In conclusion, the CCR5 Delta 32 polymorphism attenuates the adverse effects of inflammation on overall and cardiovascular mortality in ESRD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP825673.RAu-mXbnJHo5wRUzLd3aGpKdV8s-rO7i_brvXDdQ6x8-M130_provenance.
- assertion description "[In conclusion, the CCR5 Delta 32 polymorphism attenuates the adverse effects of inflammation on overall and cardiovascular mortality in ESRD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP765261.RAas4Cfc6-llaQq4htHC5yLvS1J1pOo8riDF1tHit9ROE130_assertion description "[In conclusion, the CCR5 Delta 32 polymorphism attenuates the adverse effects of inflammation on overall and cardiovascular mortality in ESRD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP765261.RAas4Cfc6-llaQq4htHC5yLvS1J1pOo8riDF1tHit9ROE130_provenance.
- NP534996.RA2VGlEeDQtmH_q4Cnr2FEbqpLkByTBDKNKc-3wchXD2U130_assertion description "[In conclusion, the CCR5 Delta 32 polymorphism attenuates the adverse effects of inflammation on overall and cardiovascular mortality in ESRD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP534996.RA2VGlEeDQtmH_q4Cnr2FEbqpLkByTBDKNKc-3wchXD2U130_provenance.
- NP117426.RAhJp7_BIrzsGdr3ut3hs1QwGGTCbk58tSC6qq3mKvcHk130_assertion description "[In conclusion, the CCR5 Delta 32 polymorphism attenuates the adverse effects of inflammation on overall and cardiovascular mortality in ESRD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP117426.RAhJp7_BIrzsGdr3ut3hs1QwGGTCbk58tSC6qq3mKvcHk130_provenance.
- NP316958.RAhtIa1lAcngJGjjlRhC0BvLyObV4LOwFExz3Q4U3nAjA130_assertion description "[In conclusion, the CCR5 Delta 32 polymorphism attenuates the adverse effects of inflammation on overall and cardiovascular mortality in ESRD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP316958.RAhtIa1lAcngJGjjlRhC0BvLyObV4LOwFExz3Q4U3nAjA130_provenance.
- NP734364.RAfoerk7TqlhWK_Crw9F2Ij87iPIByyp72vQ7mgAvd7Yg130_assertion description "[In conclusion, the CCR5 Delta 32 polymorphism attenuates the adverse effects of inflammation on overall and cardiovascular mortality in ESRD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP734364.RAfoerk7TqlhWK_Crw9F2Ij87iPIByyp72vQ7mgAvd7Yg130_provenance.
- NP317051.RA_vHRrurMR5naDpKuaWYC3_8hm_4v8bnFO_ucLmfQqTs130_assertion description "[In conclusion, the CCR5 Delta 32 polymorphism attenuates the adverse effects of inflammation on overall and cardiovascular mortality in ESRD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP317051.RA_vHRrurMR5naDpKuaWYC3_8hm_4v8bnFO_ucLmfQqTs130_provenance.
- NP734365.RAM6UqtE6443EqUdENnAvlNvKC6vTso2rAdQkJW7YyXXs130_assertion description "[In conclusion, the CCR5 Delta 32 polymorphism attenuates the adverse effects of inflammation on overall and cardiovascular mortality in ESRD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP734365.RAM6UqtE6443EqUdENnAvlNvKC6vTso2rAdQkJW7YyXXs130_provenance.
- NP146041.RAwREYRujZp0KJLhku6f5HEsefg6hUpN1H3yrm9nHneSE130_assertion description "[In conclusion, the CCR5 Delta 32 polymorphism attenuates the adverse effects of inflammation on overall and cardiovascular mortality in ESRD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP146041.RAwREYRujZp0KJLhku6f5HEsefg6hUpN1H3yrm9nHneSE130_provenance.